Aria Neurosciences, Inc.
Aria Neurosciences, Inc. (Aria) is an emerging biopharmaceutical company dedicated to developing and commercializing novel disease modifying therapies for Alzheimer (AD) and other neurological diseases. We have identified a preclinical lead compound, ARN-2966 from Arias chemical library. The mechanism of action (MOA) of ARN2966 is currently under study and appears to be novel. ARN2966 reduces expression of APP with resultant lower production of A. This potent post-transcriptional modulation of APP expression differs from other mechanisms such as inhibition of secretases. Secretase inhibitors have been pursued as disease modifying strategies by a number of pharmaceutical firms but they have encountered numerous setbacks during clinical development.
Aria Neurosciences, Inc.
Aria Neurosciences, Inc. (Aria) is an emerging biopharmaceutical company dedicated to developing and commercializing novel disease modifying therapies for Alzheimer (AD) and other neurological diseases. We have identified a preclinical lead compound, ARN-2966 from Arias chemical library. The mechanism of action (MOA) of ARN2966 is currently under study and appears to be novel. ARN2966 reduces expression of APP with resultant lower production of A. This potent post-transcriptional modulation of APP expression differs from other mechanisms such as inhibition of secretases. Secretase inhibitors have been pursued as disease modifying strategies by a number of pharmaceutical firms but they have encountered numerous setbacks during clinical development.
arianeurosciences.com
295 Washington Ave, Suite S Hamden, Connecticut 06410, US
Details
Year founded
2010
Revenue
1M-5M
Employees
1-10
Number of locations
1
NAICS
3254
SIC
2834
Products & Services
Outlines the company's specialized services and operational strengths.
- Amyloid-Related Imaging Abnormalities (ARIA) detection
- Clinical management of ARIA
- Contact us in order to access
Equipment
Provides a detailed list of machinery and tools utilized on the company's premises.
- NGF Stimulator
- NGF Gene Expression Analyzer
- NGF Secretion Measurement Device
- Contact us in order to access
Ramping up production
Indicates the company's current production trend and growth trajectory.
TRUE
Our production algorithm is showing that aria neurosciences is ramping up production.
Target industries
Locations (1)
Aria Neurosciences, Inc.
295 Washington Ave, Suite S Hamden, Connecticut 06410, US
People Also Searched For
Frequently Asked Questions
What services & capabilities does Aria Neurosciences, Inc. offer?
Aria Neurosciences, Inc. offers a range of services and capabilities, including Amyloid-Related Imaging Abnormalities (ARIA) detection.
What kind of equipment does Aria Neurosciences, Inc. use?
Aria Neurosciences, Inc. uses a variety of equipment, including NGF Stimulator.
What are the target industries of Aria Neurosciences, Inc.?
Aria Neurosciences, Inc. serves several industries, including the medical industry.
How many locations does Aria Neurosciences, Inc. operate?
Aria Neurosciences, Inc. operates from a single location at 295 washington avenue suite south, hamden, connecticut 06410, united states.
Where are the headquarters of Aria Neurosciences, Inc.?
The headquarters of Aria Neurosciences, Inc. are located in 295 washington avenue suite south, hamden, connecticut 06410, united states.
What is the NAICS code for Aria Neurosciences, Inc.?
The NAICS code for Aria Neurosciences, Inc. is 3254.
How many employees does Aria Neurosciences, Inc. have?
Aria Neurosciences, Inc. has an employee count in the range of 1-10 employees.
What is the official website of Aria Neurosciences, Inc.?
The official website of Aria Neurosciences, Inc. is https://www.arianeurosciences.com/.
When was Aria Neurosciences, Inc. founded?
Aria Neurosciences, Inc. was founded in 2010.